Treatment of Tourette Syndrome in Children with N-Acetylcysteine (NAC)


To determine whether N-Acetylcysteine (NAC) is effective in treating children with Tourette syndrome (TS).

Criteria for Participation

  • Children 8-17 with chronic Tourette syndrome.

Research Components

Subjects receive active N-Acetylcysteine (a natural supplement) or a placebo and can remain on current medications. Treatment is free and participants are paid up to $150 for participation in the study.


Please contact us for further information if you are interested in participating in this new study at the Yale Child Study Center.

Jilian Mulqueen 
(203) 737-4809